| scholarly article | Q13442814 |
| P2093 | author name string | Ke-Qin Zhang | |
| Yun Zhou | |||
| Ying Xue | |||
| Xian-Zheng Wu | |||
| Min-Dan Xu | |||
| P2860 | cites work | Type 1 and type 2 diabetic patients display different patterns of cellular microparticles | Q44114915 |
| Detached endothelial cells and microparticles as sources of tissue factor activity | Q46669220 | ||
| Proteome analysis reveals antiangiogenic environments in chronic wounds of diabetes mellitus type 2 patients | Q50880864 | ||
| Tissue factor pathway inhibitor on circulating microparticles in acute myocardial infarction | Q51558965 | ||
| Microparticles bearing tissue factor and tissue factor pathway inhibitor in gestational vascular complications | Q51751418 | ||
| A Role for MRP8 in in stent restenosis in diabetes | Q59708296 | ||
| Platelet-derived microparticle count and surface molecule expression differ between subjects with and without type 2 diabetes, independently of obesity status | Q63488621 | ||
| Coagulation factor IXa binding to activated platelets and platelet-derived microparticles: a flow cytometric study | Q68030006 | ||
| Platelet-derived microparticles express high affinity receptors for factor VIII | Q68254374 | ||
| Loss of membrane phospholipid asymmetry in platelets and red cells may be associated with calcium-induced shedding of plasma membrane and inhibition of aminophospholipid translocase | Q68346189 | ||
| The Nature and Significance of Platelet Products in Human Plasma | Q72220665 | ||
| Microvesicles bind soluble fibrinogen, adhere to immobilized fibrinogen and coaggregate with platelets | Q74286748 | ||
| Leukocyte microparticles stimulate endothelial cell cytokine release and tissue factor induction in a JNK1 signaling pathway | Q78101699 | ||
| Circulating tissue factor positive microparticles in patients with acute recurrent deep venous thrombosis | Q82591079 | ||
| Effects of pioglitazone versus metformin on circulating endothelial microparticles and progenitor cells in patients with newly diagnosed type 2 diabetes--a randomized controlled trial | Q83262388 | ||
| Involvement of microparticles in diabetic vascular complications | Q84465761 | ||
| Role of microparticles in sepsis | Q26996517 | ||
| Microparticles, vascular function, and atherothrombosis | Q27016063 | ||
| Intracellular and extracellular roles of S100 proteins | Q28184555 | ||
| Universal sample preparation method for proteome analysis | Q29615662 | ||
| Mechanism of apoptosis induced by S100A8/A9 in colon cancer cell lines: the role of ROS and the effect of metal ions. | Q33201339 | ||
| Proteome of endothelial cell-derived procoagulant microparticles | Q33225051 | ||
| Endothelial microparticles induce formation of platelet aggregates via a von Willebrand factor/ristocetin dependent pathway, rendering them resistant to dissociation | Q33366697 | ||
| Type 2 diabetes: one disease, multiple cardiovascular risk factors. | Q33590100 | ||
| Flow cytometric analysis of circulating microparticles in plasma | Q34059037 | ||
| Diabetes mellitus: a hypercoagulable state | Q34190414 | ||
| Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis | Q34635642 | ||
| Procoagulant activity, but not number, of microparticles increases with age and in individuals after a single venous thromboembolism | Q34788985 | ||
| Microparticles in hemostasis and thrombosis. | Q35131040 | ||
| Type 2 diabetes: an atherothrombotic syndrome | Q36126667 | ||
| Platelets in inflammation and atherogenesis. | Q36328825 | ||
| Detection and measurement of microparticles: an evolving research tool for vascular biology | Q37050566 | ||
| The expression of inflammatory genes is upregulated in peripheral blood of patients with type 1 diabetes | Q37106490 | ||
| Microparticles, thrombosis and cancer | Q37414580 | ||
| The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer | Q37487325 | ||
| Cellular Mechanisms Underlying the Formation of Circulating Microparticles | Q37821168 | ||
| The many faces of endothelial microparticles. | Q37821169 | ||
| Mechanisms determining course and outcome of diabetic patients who have had acute myocardial infarction | Q38559349 | ||
| Standardization of pre-analytical variables in plasma microparticle determination: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop. | Q39590400 | ||
| Activated platelet and oxidized LDL induce endothelial membrane vesiculation: clinical significance of endothelial cell-derived microparticles in patients with type 2 diabetes | Q40536806 | ||
| Arachidonic acid in platelet microparticles up-regulates cyclooxygenase-2-dependent prostaglandin formation via a protein kinase C/mitogen-activated protein kinase-dependent pathway | Q40969063 | ||
| Platelets microparticles as a link between micro- and macro-angiopathy in young patients with type 1 diabetes | Q41166174 | ||
| Proteomics of microparticles after deep venous thrombosis. | Q42455347 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | type 2 diabetes | Q3025883 |
| P304 | page(s) | 209-220 | |
| P577 | publication date | 2016-01-15 | |
| P1433 | published in | American Journal of Translational Research | Q4744272 |
| P1476 | title | Proteomic characteristics of circulating microparticles in patients with newly-diagnosed type 2 diabetes | |
| P478 | volume | 8 |
| Q64118176 | Circulating microparticle subpopulation in metabolic syndrome: relation to oxidative stress and coagulation markers |
| Q92328545 | Coagulatory Defects in Type-1 and Type-2 Diabetes |
| Q64237035 | Molecular Mechanisms Underpinning Microparticle-Mediated Cellular Injury in Cardiovascular Complications Associated with Diabetes |
Search more.